Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
48.17 Mб
Скачать

Contents

Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

v

Elia J. Duh

 

Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ix

PART I CLINICAL ASPECTS OF DIABETIC RETINOPATHY

 

1

Nonproliferative Diabetic Retinopathy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3

 

Catherine B. Meyerle, Emily Y. Chew, and Frederick L. Ferris III

 

2

Proliferative Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

29

 

Ronald P. Danis and Matthew D. Davis

 

3

The Epidemiology of Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . .

67

 

Ronald Klein

 

4

Diagnostic Modalities in Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . .

109

 

Ron Margolis and Peter K. Kaiser

 

PART II PATHOPHYSIOLOGY / BASIC RESEARCH

 

5

In Vivo Models of Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . .

137

 

Timothy S. Kern

 

A PATHWAYS OF HYPERGLYCEMIA-INDUCED DAMAGE

 

6

The Polyol Pathway and Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . .

159

 

Mara Lorenzi and Peter J. Oates

 

7

The Role of Advanced Glycation in Diabetic Retinopathy . . . . . . . . . . . . . .

187

 

Alan W. Stitt

 

8

The Role of Protein Kinase C in Diabetic Retinopathy . . . . . . . . . . . . . . . . .

207

 

Manvi Prakash, Jennifer K. Sun, and George L. King

 

9

Oxidative Stress in Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . .

217

 

Ruth B. Caldwell, Azza E.B. El-Remessy, and Robert W. Caldwell

 

B PATHOPHYSIOLOGICAL PROCESS IN DIABETIC RETINOPATHY

 

10

Pericyte Loss in the Diabetic Retina. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

245

 

Frederick Pfister, Yuxi Feng, and Hans-Peter Hammes

 

vii

viii

Contents

11 Capillary Dropout in Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . 265

Renu A. Kowluru and Pooi-See Chan

12 Neuroglial Dysfunction in Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . 283

Heather D. VanGuilder, Thomas W. Gardner, and Alistair J. Barber

13 The Role of Inflammation in the Pathophysiology

of Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303

Lauren E. Swenarchuk, Linda E. Whetter, and Anthony P. Adamis

14 Vascular Permeability in Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . 333

David A. Antonetti, Heather D. VanGuilder, and Cheng Mao-Lin

15 Retinal Neovascularization and the Role of VEGF . . . . . . . . . . . . . . . . . . . . 353

Elia J. Duh

16Beyond VEGF – Other Factors Important

in Retinal Neovascularization: Potential Targets

in Proliferative Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 375

Arup Das, Deepti Navaratna, and Paul G. McGuire

PART III EMERGING TREATMENTS AND CONCEPTS IN DIABETIC RETINOPATHY

17 Anti-VEGF Therapy as an Emerging Treatment

for Diabetic Retinopathy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 401

Diana V. Do, Julia A. Haller, Anthony P. Adamis,

Carla Striata, Quan Dong Nguyen, Syed Mahmood Shah, and Antonia M. Joussen

18 Clinical Trials in Protein Kinase C-β Inhibition in Diabetic Retinopathy . . . 423

Jennifer K. Sun, Rola Hamam, and Lloyd P. Aiello

19 The Role of Intravitreal Steroids in the Management

of Diabetic Retinopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 435

Mark C. Gillies

20 Antagonism of the Growth Hormone

Axis as a Therapeutic Strategy for Diabetic Retinopathy. . . . . . . . . . . . . . . . 449

Alexander V. Ljubimov, Michael Boulton, Sergio Caballero, and Maria B. Grant

21 Diabetic Retinopathy and Systemic Complications . . . . . . . . . . . . . . . . . . . . 466

Ning Cheung and Tien Y. Wong

Name Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 483

Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 489